Dr. Donington is a Professor in Surgery and chief of the section of Thoracic Surgery. Her clinical and interests focus on the diagnosis and treatment of non-small cell lung cancer. Areas of expertise include the use of multimodality therapy for locally advanced lung cancer, treatment options for high-risk patients with early stage lung cancer and lung cancer in women. She is the surgical chair for the thoracic malignancy group of NRG Oncology Group, council member for the Western Thoracic Surgical Association, and immediate past-president of the New York Society for Thoracic Surgery, and the Women in Thoracic Surgery.
NYU
New York, NY
MS - Clinical Research
2010
Mayo Hospital and Clinics
Rochester, MN
- Cardiothoracic Surgery
2002
Georgetown University
Washington, DC
- General Surgery
1999
NIH/NCI/Surgery Branch
Bethesda, MD
- Surgical Oncology
1996
Rush University
Chicago, IL
MD - Medicine
1992
University of Michigan
Ann Arbor, MI
BS - Biology
1987
Surgical Management of Oligometastatic NSCLC: Pro versus Con.
Surgical Management of Oligometastatic NSCLC: Pro versus Con. Ann Thorac Surg. 2026 Sep 15.
PMID: 42744126
Executive Summary of the American Radium Society Appropriate Use Criteria for a Multidisciplinary Treatment Approach to the Management of Resectable Esophageal and Gastroesophageal Junction Adenocarcinoma.
Executive Summary of the American Radium Society Appropriate Use Criteria for a Multidisciplinary Treatment Approach to the Management of Resectable Esophageal and Gastroesophageal Junction Adenocarcinoma. Int J Radiat Oncol Biol Phys. 2026 Aug 25.
PMID: 42641667
The Paradigm Shift in Clinical Stage II Non-Small-Cell Lung Cancer Management: A Comprehensive Review of Optimal Surgical and Systemic Approaches.
The Paradigm Shift in Clinical Stage II Non-Small-Cell Lung Cancer Management: A Comprehensive Review of Optimal Surgical and Systemic Approaches. Cancers (Basel). 2026 May 22; 18(11).
PMID: 42279265
The 2026 American Association for Thoracic Surgery (AATS) expert consensus document: Surgical management of primary chest wall malignancies.
The 2026 American Association for Thoracic Surgery (AATS) expert consensus document: Surgical management of primary chest wall malignancies. J Thorac Cardiovasc Surg. 2026 May 04.
PMID: 42092501
Intraoperative arteriovenous patient sampling to assess in situ non-small cell lung cancer metabolism.
Intraoperative arteriovenous patient sampling to assess in situ non-small cell lung cancer metabolism. J Clin Invest. 2026 Mar 16; 136(6).
PMID: 41591824
What should lung cancer patients know before surgery? A Delphi consensus study.
What should lung cancer patients know before surgery? A Delphi consensus study. JTCVS Open. 2026 Feb; 29:101525.
PMID: 41960080
Understanding our thoracic surgery workforce: Who, what, and where we practice.
Understanding our thoracic surgery workforce: Who, what, and where we practice. JTCVS Open. 2025 Dec; 28:760-767.
PMID: 41473054
Surgical advocacy as an academic career path: A guide for promotion discussions.
Surgical advocacy as an academic career path: A guide for promotion discussions. Surgery. 2025 Nov; 187:109650.
PMID: 40929951
Will Care for Esophageal Squamous Cell Carcinoma Change?
Will Care for Esophageal Squamous Cell Carcinoma Change? JAMA Surg. 2025 May 01; 160(5):575.
PMID: 40105818
American Radium Society Appropriate Use Criteria Systematic Review and Guidelines on Reirradiation for Non-Small Cell Lung Cancer Executive Summary.
American Radium Society Appropriate Use Criteria Systematic Review and Guidelines on Reirradiation for Non-Small Cell Lung Cancer Executive Summary. Int J Radiat Oncol Biol Phys. 2025 09 01; 123(1):204-220.
PMID: 40185207